Skip to search formSkip to main contentSkip to account menu

0.6 ML Fondaparinux sodium 12.5 MG/ML Prefilled Syringe [Arixtra]

Known as: FONDAPARINUX SODIUM 7.5 mg in 0.6 mL SUBCUTANEOUS INJECTION, SOLUTION [ARIXTRA], 0.6 ML Arixtra 12.5 MG/ML Prefilled Syringe, Arixtra 7.5 MG in 0.6 ML Prefilled Syringe 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Glycosaminoglycans (GAGs) are carbohydrate polyionic polymers that participate in a host of critically important biological… 
Review
2012
Review
2012
Fondaparinux sodium (Arixtra®) is a synthetic, sulfated pentasaccharide, selective factor Xa inhibitor that is indicated in… 
2004
2004
Auteur(s) :, Roger Cariou* Departement therapeutique thrombose, Sanofi Synthelabo Recherche, 91385 Chilly Mazarin cedex, France… 
2004
2004
Background: The MATISSE trials showed that a single dose regimen of fondaparinux, a synthetic selective factor Xa inhibitor, was… 
2004
2004
Background: The MATISSE trials demonstrated that once-daily subcutaneous fondaparinux, a synthetic selective factor Xa inhibitor…